The Growing Complexity of Modern Oncology
Cancer care has evolved dramatically in recent years. What oncologists once treated as unified diseases are now recognized as numerous subtypes, each demanding tailored treatment approaches based on rapidly…
Background: Background: Rehabilitation is considered a fundamental component of cancer treatment, especially for patients undergoing cancer surgery. In contrast to conventional rehabilitation education, digital rehabilitation has the potential to improve patients’ access to post-operative…
Continue Reading
BREAKTHROUGH EXPANSION FOR PROSTATE CANCER THERAPY
Novartis has announced a significant development in prostate cancer treatment with the FDA‘s expanded approval of Pluvicto (lutetium Lu 177 vipivotide tetraxetan). This radioligand therapy is now available for…
Breakthrough Cancer Treatment Receives IDE Approval
Alpha Tau Medical Ltd. has achieved a significant milestone in cancer treatment innovation. The FDA has granted an Investigational Device Exemption (IDE) for a pilot study using their revolutionary…
What You Should Know:
– Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has announced a collaboration with the National Cancer Institute (NCI), part of the U.S. National Institutes of Health (NIH).
–…
Continue Reading
Dr. Sandeep Jain explores available treatment for his patients providing them options that achieve the best possible outcome and quality of life. When a 55-year-old patient arrived at Minnesota Oncology with a rare and aggressive…
Continue Reading
Yonatan (Yoni) Savir, Assoc. Prof. Faculty of Medicine at Technion
While it’s only relatively recently that AI became a household term, the technology is already having a major impact on society. But perhaps AI’s greatest…
Continue Reading
Curenetics utilises AI-driven insights to predict how patients will respond to immunotherapy, supporting clinician decision-making and improving patient outcomes.The DigitalHealth.London Launchpad company announce their latest research collaboration with the University of Pittsburgh, marking a…
Continue Reading
What You Should Know:
– Owkin, an AI-powered biotech company, today announced the dosing of the first patient in its Phase I clinical trial of OKN4395, a novel cancer therapy designed to restore immune function…
Continue Reading
Groundbreaking AI Study Transforms Cancer Diagnostics
Lunit, in partnership with Japan’s National Cancer Center Hospital East (NCCHE), has published breakthrough research in the Journal of Clinical Oncology Precision Oncology. Their study demonstrates how AI-powered pathology…
